Cargando...
Second line (disease modifying) treatment in rheumatoid arthritis: which drug for which patient?
OBJECTIVES--The objectives were to assess (a) the comparative merits of commonly used disease modifying drugs in the treatment of rheumatoid arthritis (RA) and (b) the influence of age, gender, and disease duration on the outcome of treatment. METHODS--Collected analysis (meta-analysis) was performe...
Gardado en:
| Publicado en: | Ann Rheum Dis |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
BMJ Publishing Group
1993
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC1005066/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/8100702/ https://ncbi.nlm.nih.govhttps://doi.org/10.1136/ard.52.6.423 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|